Approvable letters in the FDA new drug approval process.
Richard
B W
BW
Center for the Study of Drug Development, Tufts University, Boston, MA 02111.
Ulcickas
M
M
Lasagna
L
L
D006801:Humans; D007880:Legislation, Drug; D008004:Licensure; D013997:Time Factors; D014481:United States; D014486:United States Food and Drug Administration